Devin M Lonergan, MD
Otolaryngology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lonergan’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96479 · Current
Licensed to practise in California · since 2006 · expires 2027-10-31 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$116,756
Medicare paid this office $116,756 for 422 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 192 | $29,577 | $113 |
| New patient visit (45+ min) | 135 | $20,226 | $150 |
| Exam to assess movement of vocal cord flaps using an endoscope | 78 | $16,710 | $194 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $10,695 | $191 |
| Removal of impacted ear wax | 145 | $7,868 | $42 |
See all 9 services
| Return visit (30+ min) | 192 | $29,577 | $113 |
| New patient visit (45+ min) | 135 | $20,226 | $150 |
| Exam to assess movement of vocal cord flaps using an endoscope | 78 | $16,710 | $194 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $10,695 | $191 |
| Removal of impacted ear wax | 145 | $7,868 | $42 |
| Short return visit (20+ min) | 59 | $6,859 | $76 |
| Control of bleeding of nose using an endoscope | 22 | $6,740 | $241 |
| New patient visit (30+ min) | 58 | $4,652 | $80 |
| Long return visit (40+ min) | 14 | $2,372 | $169 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
422 Original Medicare patients in 2024. Average age 77 · Women 59% · Also on Medicaid 5% · Health risk score 0.91. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 61% · Coronary heart disease 23% · Atrial fibrillation 16% · Diabetes 15% · Chronic kidney disease 15% · Cancer 15% · Heart failure 11% · Depression 11% · COPD 7% · Stroke 5% · Dementia 3%.
The office billed $522,111, Medicare allowed $156,954 and paid $116,756; for 979 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 422 | 979 | 77 | 0.91 | $522,111 | $116,756 |
| 2023 | 402 | 949 | 77 | 0.88 | $468,847 | $111,473 |
| 2022 | 430 | 1,034 | 76 | 0.86 | $492,235 | $119,902 |
| 2021 | 408 | 1,064 | 77 | 0.89 | $462,788 | $117,501 |
| 2020 | 319 | 797 | 77 | 1.08 | $347,196 | $82,485 |
| 2019 | 397 | 952 | 77 | 1.07 | $433,839 | $100,336 |
| 2018 | 401 | 980 | 77 | 0.99 | $420,620 | $101,902 |
| 2017 | 418 | 1,073 | 76 | 1.04 | $434,223 | $105,301 |
| 2016 | 362 | 908 | 76 | 0.96 | $374,686 | $95,992 |
| 2015 | 495 | 1,352 | 75 | 1.14 | $400,949 | $117,350 |
| 2014 | 704 | 3,334 | 74 | 1.17 | $732,066 | $245,319 |
| 2013 | 690 | 3,825 | 74 | 1.22 | $821,214 | $281,901 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 151 | $21,933 | $117 |
| New patient visit (45+ min) | 112 | $17,023 | $152 |
| Exam to assess movement of vocal cord flaps using an endoscope | 64 | $13,503 | $202 |
| Diagnostic exam of nasal passages using an endoscope | 55 | $12,897 | $198 |
| Short return visit (20+ min) | 111 | $12,616 | $78 |
| Removal of impacted ear wax | 131 | $6,664 | $40 |
| New patient visit (30+ min) | 82 | $6,609 | $81 |
| Control of bleeding of nose using an endoscope | 20 | $5,975 | $249 |
2022: 8 services
| Short return visit (20+ min) | 179 | $20,771 | $80 |
| New patient visit (30+ min) | 188 | $18,186 | $97 |
| Exam to assess movement of vocal cord flaps using an endoscope | 65 | $15,224 | $198 |
| Return visit (30+ min) | 96 | $12,498 | $118 |
| Diagnostic exam of nasal passages using an endoscope | 49 | $11,750 | $199 |
| New patient visit (45+ min) | 47 | $6,595 | $140 |
| Removal of impacted ear wax | 130 | $6,544 | $40 |
| Control of bleeding of nose using an endoscope | 20 | $5,675 | $247 |
2021: 9 services
| Short return visit (20+ min) | 166 | $22,424 | $83 |
| New patient visit (30+ min) | 146 | $13,851 | $95 |
| Exam to assess movement of vocal cord flaps using an endoscope | 60 | $13,121 | $202 |
| Return visit (30+ min) | 102 | $13,020 | $117 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $10,599 | $204 |
| New patient visit (45+ min) | 65 | $9,348 | $144 |
| Removal of impacted ear wax | 158 | $8,956 | $42 |
| Control of bleeding of nose using an endoscope | 14 | $4,239 | $249 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $597 | $46 |
2020: 9 services
| Short return visit (20+ min) | 138 | $15,128 | $66 |
| New patient visit (30+ min) | 114 | $10,419 | $91 |
| Return visit (30+ min) | 78 | $8,531 | $102 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $8,517 | $203 |
| Exam to assess movement of vocal cord flaps using an endoscope | 37 | $7,983 | $195 |
| Removal of impacted ear wax | 97 | $5,741 | $40 |
| New patient visit (45+ min) | 30 | $4,228 | $141 |
| Control of bleeding of nose using an endoscope | 15 | $3,548 | $237 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 11 | $543 | $49 |
2019: 10 services
| Short return visit (20+ min) | 140 | $15,607 | $67 |
| New patient visit (30+ min) | 139 | $12,872 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 39 | $11,015 | $204 |
| Exam to assess movement of vocal cord flaps using an endoscope | 55 | $10,987 | $174 |
| Return visit (30+ min) | 105 | $10,379 | $93 |
| Control of bleeding of nose using an endoscope | 28 | $9,314 | $245 |
| New patient visit (45+ min) | 40 | $6,029 | $151 |
| Removal of impacted ear wax | 116 | $5,920 | $41 |
| Diagnostic exam of voice box using a flexible endoscope | 18 | $1,907 | $100 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $585 | $45 |
2018: 10 services
| Diagnostic exam of nasal passages using an endoscope | 65 | $17,819 | $210 |
| Short return visit (20+ min) | 158 | $16,304 | $62 |
| New patient visit (30+ min) | 129 | $11,329 | $88 |
| Return visit (30+ min) | 110 | $10,427 | $90 |
| Exam to assess movement of vocal cord flaps using an endoscope | 43 | $9,543 | $165 |
| Removal of impacted ear wax | 112 | $6,439 | $40 |
| New patient visit (45+ min) | 32 | $4,670 | $146 |
| Control of bleeding of nose using an endoscope | 11 | $4,278 | $252 |
| Diagnostic exam of voice box using a flexible endoscope | 18 | $2,875 | $111 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 20 | $888 | $44 |
2017: 11 services
| Short return visit (20+ min) | 156 | $17,258 | $62 |
| New patient visit (30+ min) | 175 | $14,993 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 42 | $11,993 | $210 |
| Return visit (30+ min) | 100 | $10,071 | $93 |
| Exam to assess movement of vocal cord flaps using an endoscope | 44 | $8,690 | $167 |
| Removal of impacted ear wax | 117 | $6,630 | $41 |
| Control of bleeding of nose using an endoscope | 20 | $5,430 | $247 |
| New patient visit (45+ min) | 40 | $5,260 | $131 |
| Diagnostic exam of voice box using a flexible endoscope | 42 | $5,196 | $108 |
| Long return visit (40+ min) | 11 | $1,487 | $135 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 | $809 | $48 |
2016: 11 services
| New patient visit (30+ min) | 164 | $14,867 | $91 |
| Short return visit (20+ min) | 128 | $12,880 | $65 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $9,967 | $212 |
| Return visit (30+ min) | 85 | $8,326 | $95 |
| Exam to assess movement of vocal cord flaps using an endoscope | 31 | $7,197 | $200 |
| Diagnostic exam of voice box using a flexible endoscope | 52 | $6,220 | $111 |
| Removal of impacted ear wax | 105 | $6,208 | $43 |
| Control of bleeding of nose using an endoscope | 16 | $4,978 | $249 |
| New patient visit (45+ min) | 29 | $4,152 | $143 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 19 | $884 | $47 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $436 | $40 |
2015: 13 services
| New patient visit (30+ min) | 203 | $19,521 | $96 |
| Short return visit (20+ min) | 210 | $15,505 | $54 |
| Diagnostic exam of nasal passages using an endoscope | 56 | $13,874 | $195 |
| Diagnostic exam of voice box using a flexible endoscope | 77 | $9,440 | $107 |
| Return visit (30+ min) | 81 | $8,668 | $103 |
| Removal of impacted ear wax | 132 | $6,388 | $41 |
| Control of bleeding of nose using an endoscope | 21 | $5,968 | $239 |
| Exam to assess movement of vocal cord flaps using an endoscope | 27 | $5,535 | $198 |
| New patient visit (45+ min) | 30 | $4,611 | $154 |
| Exam of ear using a microscope | 67 | $2,107 | $30 |
| Comprehensive hearing and speech recognition test | 31 | $649 | $21 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $529 | $41 |
| Test to assess middle ear function | 26 | $204 | $8 |
2014: 19 services
| Diagnostic exam of nasal passages using an endoscope | 137 | $41,183 | $172 |
| Short return visit (20+ min) | 407 | $40,978 | $55 |
| New patient visit (30+ min) | 306 | $24,476 | $80 |
| Diagnostic exam of voice box using a flexible endoscope | 147 | $18,448 | $92 |
| Control of bleeding of nose using an endoscope | 44 | $13,811 | $203 |
| Return visit (30+ min) | 134 | $11,712 | $77 |
| Removal of impacted ear wax | 188 | $10,912 | $36 |
| New patient visit (45+ min) | 64 | $7,605 | $119 |
| Exam to assess movement of vocal cord flaps using an endoscope | 32 | $7,495 | $170 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 15 | $5,484 | $249 |
| Comprehensive hearing and speech recognition test | 172 | $5,032 | $28 |
| Ct scan of face without contrast | 34 | $3,743 | $110 |
| Exam of ear using a microscope | 113 | $3,434 | $25 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 53 | $2,255 | $43 |
| Test to assess middle ear function | 118 | $1,290 | $11 |
| Evaluation and testing for balance with recording | 11 | $840 | $76 |
| Test for eardrum and muscle function | 44 | $681 | $15 |
| Assessment and recording of balance system during irrigation of both ears | 11 | $513 | $13 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $426 | $33 |
2013: 23 services
| Diagnostic exam of nasal passages using an endoscope | 151 | $51,540 | $180 |
| Short return visit (20+ min) | 369 | $39,399 | $56 |
| New patient visit (30+ min) | 287 | $22,071 | $77 |
| Diagnostic exam of voice box using a flexible endoscope | 142 | $19,725 | $94 |
| Return visit (30+ min) | 196 | $18,657 | $80 |
| New patient visit (45+ min) | 105 | $12,406 | $118 |
| Control of bleeding of nose using an endoscope | 35 | $12,244 | $255 |
| Removal of impacted ear wax | 168 | $10,224 | $39 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 21 | $10,136 | $317 |
| Exam to assess movement of vocal cord flaps using an endoscope | 40 | $10,109 | $177 |
| Incision of fluid canal of inner ear with infusion of drugs | 12 | $6,662 | $167 |
| Comprehensive hearing and speech recognition test | 178 | $5,478 | $29 |
| Ct scan of face without contrast | 27 | $4,237 | $146 |
| Exam of ear using a microscope | 110 | $3,813 | $25 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 45 | $1,867 | $41 |
| Test for eardrum and muscle function | 87 | $1,451 | $16 |
| Removal of foreign body in ear canal | 12 | $1,345 | $112 |
| Evaluation and testing for balance with recording | 15 | $1,194 | $80 |
| Test to assess middle ear function | 94 | $1,097 | $11 |
| Assessment and recording of balance system during irrigation of both ears | 15 | $729 | $13 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $524 | $35 |
| Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes | 13 | $357 | $27 |
| Injection, dexamethasone sodium phosphate, 1 mg | 12 | $34 | None |
Drugs they prescribed that Part D paid
$6,923
Pharmacies billed $6,923 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
270 generic and fewer than 11 brand-name prescriptions · $6,923 in drug cost · 31 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 61 | $1,569 | $26 |
| Ipratropium | 18 | $1,203 | $67 |
| Famotidine | 44 | $623 | $14 |
| Omeprazole | 24 | $329 | $14 |
| Azithromycin | 11 | $177 | $16 |
See all 7 drugs
| Fluticasone Propionate | 61 | $1,569 | $26 |
| Ipratropium | 18 | $1,203 | $67 |
| Famotidine | 44 | $623 | $14 |
| Omeprazole | 24 | $329 | $14 |
| Azithromycin | 11 | $177 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $154 | $13 |
| Prednisone | 24 | $116 | $5 |
Year by year
| 2024 | 276 | 103 | None | None | $6,923 |
| 2023 | 298 | 104 | None | 5% | $8,793 |
| 2022 | 294 | 104 | None | None | $7,005 |
| 2021 | 275 | 92 | None | None | $6,889 |
| 2020 | 214 | 79 | None | 6% | $7,420 |
| 2019 | 238 | 90 | None | 6% | $7,907 |
| 2018 | 250 | 97 | None | None | $6,391 |
| 2017 | 259 | 109 | 5% (12) | 11% | $9,196 |
| 2016 | 226 | 99 | 5% (11) | 10% | $8,119 |
| 2015 | 376 | 147 | None | 5% | $8,941 |
| 2014 | 761 | 238 | 3% (25) | 8% | $27,176 |
| 2013 | 818 | 232 | 6% (49) | 5% | $27,145 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Fluticasone Propionate | 64 | $1,441 | $23 |
| Omeprazole | 30 | $491 | $16 |
| Famotidine | 35 | $431 | $12 |
| Gabapentin | 24 | $265 | $11 |
| Azithromycin | 15 | $240 | $16 |
| Montelukast | 16 | $173 | $11 |
| Prednisone | 18 | $84 | $5 |
2022: 8 drugs
| Fluticasone Propionate | 86 | $1,479 | $17 |
| Omeprazole | 34 | $450 | $13 |
| Gabapentin | 14 | $423 | $30 |
| Famotidine | 38 | $295 | $8 |
| Azithromycin | 11 | $255 | $23 |
| Amoxicillin-Clavulanate Potass | 11 | $248 | $23 |
| Topiramate | 11 | $130 | $12 |
| Prednisone | 21 | $98 | $5 |
2021: 4 drugs
| Fluticasone Propionate | 91 | $1,997 | $22 |
| Omeprazole | 39 | $609 | $16 |
| Famotidine | 38 | $282 | $7 |
| Prednisone | 11 | $50 | $5 |
2020: 4 drugs
| Fluticasone Propionate | 79 | $1,668 | $21 |
| Omeprazole | 13 | $254 | $20 |
| Famotidine | 15 | $83 | $6 |
| Prednisone | 12 | $54 | $5 |
2019: 6 drugs
| Fluticasone Propionate | 69 | $1,119 | $16 |
| Amoxicillin-Clavulanate Potass | 14 | $277 | $20 |
| Omeprazole | 21 | $265 | $13 |
| Ranitidine | 18 | $150 | $8 |
| Prednisone | 18 | $82 | $5 |
| Famotidine | 12 | $60 | $5 |
2018: 6 drugs
| Fluticasone Propionate | 67 | $879 | $13 |
| Amoxicillin-Clavulanate Potass | 13 | $254 | $20 |
| Omeprazole | 17 | $246 | $14 |
| Doxycycline Monohydrate | 13 | $179 | $14 |
| Ranitidine | 22 | $151 | $7 |
| Prednisone | 23 | $126 | $5 |
2017: 7 drugs
| Fluticasone Propionate | 50 | $901 | $18 |
| Ranitidine | 21 | $323 | $15 |
| Amoxicillin-Clavulanate Potass | 14 | $245 | $18 |
| Doxycycline Monohydrate | 15 | $245 | $16 |
| Omeprazole | 22 | $222 | $10 |
| Ciprofloxacin | 12 | $95 | $8 |
| Prednisone | 19 | $89 | $5 |
2016: 6 drugs
| Dymista | 11 | $2,314 | $210 |
| Fluticasone Propionate | 71 | $878 | $12 |
| Fluconazole | 14 | $275 | $20 |
| Amoxicillin-Clavulanate Potass | 14 | $265 | $19 |
| Prednisone | 29 | $151 | $5 |
| Omeprazole | 12 | $100 | $8 |
2015: 6 drugs
| Fluticasone Propionate | 162 | $1,823 | $11 |
| Omeprazole | 77 | $921 | $12 |
| Montelukast | 11 | $230 | $21 |
| Famotidine | 12 | $103 | $9 |
| Pantoprazole | 15 | $94 | $6 |
| Prednisone | 16 | $81 | $5 |
2014: 14 drugs
| Dexilant | 22 | $5,864 | $267 |
| Fluticasone Propionate | 265 | $4,631 | $17 |
| Nasonex | 11 | $3,529 | $321 |
| Omeprazole | 148 | $1,554 | $10 |
| Montelukast | 31 | $767 | $25 |
| Amox Tr-Potassium Clavulanate | 19 | $520 | $27 |
| Azithromycin | 21 | $428 | $20 |
| Pantoprazole | 22 | $303 | $14 |
| Ofloxacin | 14 | $261 | $19 |
| Famotidine | 25 | $227 | $9 |
| Prednisone | 30 | $177 | $6 |
| Clindamycin | 11 | $176 | $16 |
| Hydrocodone-Acetaminophen | 24 | $172 | $7 |
| Mupirocin | 11 | $124 | $11 |
2013: 19 drugs
| Fluticasone Propionate | 245 | $7,160 | $29 |
| Dexilant | 15 | $4,127 | $275 |
| Nasonex | 11 | $2,680 | $244 |
| Omeprazole | 121 | $2,081 | $17 |
| Amox Tr-Potassium Clavulanate | 42 | $1,557 | $37 |
| Lansoprazole | 16 | $1,513 | $95 |
| Doxycycline Hyclate | 14 | $1,455 | $104 |
| Montelukast | 33 | $1,144 | $35 |
| Ipratropium | 26 | $622 | $24 |
| Hydrocodone-Acetaminophen | 44 | $517 | $12 |
| Azithromycin | 11 | $267 | $24 |
| Mupirocin | 20 | $258 | $13 |
| Ofloxacin | 18 | $240 | $13 |
| Ciprofloxacin | 20 | $226 | $11 |
| Prednisone | 49 | $185 | $4 |
| Famotidine | 15 | $170 | $11 |
| Pantoprazole | 12 | $111 | $9 |
| Triamterene-Hctz | 13 | $95 | $7 |
| Ranitidine | 11 | $61 | $6 |
Money from drug and device companies
$212 in 2025
| 2025 | 3 | 3 | None | $212 |
| 2023 | 1 | 1 | None | $16 |
| 2021 | 1 | 2 | None | $75 |
| 2019 | 1 | 2 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $125 | 1 payment
|
| Ethicon US | Harmonic | $60 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $26 | 1 payment
|
See all 3 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-27 | Tezspire | $26 |
| GlaxoSmithKline | Meals · 2025-06-25 | Nucala | $125 |
| Ethicon US | Meals · 2025-03-07 | Harmonic | $60 |
See earlier years (2023, 2021, 2019)
2023: $16
| Smith+Nephew | Halo | $16 | 1 payment
|
2021: $75
| Intersect ENT | Sinuva | $75 | 2 payments
|
2019: $47
| Smith+Nephew | Coblation - Tonsil Wands | $47 | 2 payments
|
Professional record
- NPI
- 1609062744
- Licence
- CA A96479California A96479: Current · expires 2027-10-31
- Trained
- University of Texas Southwestern Medical School at Dallas, 2005
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 1609062744
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-09-21
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.